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A B S T R A C T
Aims: Myocardial injury (MI) is the principal cause of death from cardiovascular disease (CVD). The present
study was conducted to investigate the ameliorative and antioxidant eﬀects of cerebrolysin (CBL) on iso-
proterenol-induced MI in rats.
Methods: MI was induced in the rats by subcutaneously injecting 100mg/kg of isoproterenol (ISO) in the ﬁrst
two days. The serum levels of creatine phosphokinase (CK-MB) and cardiac troponin I (cTnI) were measured on
the third day to conﬁrm MI. The post-treatment involved intraperitoneally injecting 5ml/kg of CBL for 7 days.
Nitric oxide (NO), malondialdehyde (MDA) in the heart tissue and catalase (CAT) and serum levels of superoxide
dismutase (SOD) and glutathione peroxidase (GPX) were measured on the 10th day using the enzyme-linked
immunosorbent assay (ELISA). Histopathological examinations of the heart tissue were also performed.
Findings: The present results suggested signiﬁcant increases in CK-MB, cTnI, MDA and NO. A signiﬁcant decrease
was also observed in the ISO-treated rats in certain antioxidant enzymes, including CAT and GPX. CBL ad-
ministration showed a signiﬁcant ameliorative increase against the oxidative ISO-induced damage. Moreover,
the histopathological ﬁndings showed lower levels of the inﬁltration of inﬂammatory cells and edema and
vascular proliferation in the CBL-treated rats.
Signiﬁcance: The present histopathological and biochemical ﬁndings attributed antioxidant properties to CBL in
the rat myocardium and suggested protective eﬀects on ISO-induced MI.
1. Introduction
Myocardial injury (MI) is a common ischemic heart condition and
the principal cause of death from cardiovascular disease (CVD) in in-
dustrialized and developing countries [1,2]. The World Health Orga-
nization has predicted that CVD will be the most signiﬁcant cause of
mortality in the world [2]. A critical imbalance between the coronary
blood supply and myocardial demand causes MI [3]. The accumulation
of free radicals has been reported as a mechanism contributing to MI
[4].
Research suggests that oxidative stress caused by the generation of
reactive oxygen species (ROS) during ischemic damage plays a key role
in developing MI [2,5]. ROS can attack intra-membranous poly-
unsaturated fatty acids (PUFA), and cause chain reactions of lipid
peroxidation (LPO) in the membrane [6,7]. Increased tissue levels of
malondialdehyde (MDA), as an important LPO by-product, can con-
tribute to the increased generation of free radicals and decreased ac-
tivities of the antioxidant system [8]. Antioxidant enzymes such as
catalase (CAT), superoxide dismutase (SOD) and gluthatione peroxidase
(GPX) considered the ﬁrst-line cellular defense against oxidative stress
eliminate ROS in tissues [1].
Nitric oxide (NO) in the heart can regulate many functions, in-
cluding heart rate and myocardial oxygen consumption [9]. Diﬀerent
endogenous systems produce ROS and reactive nitrogen species (RNS)
in normal conditions. Nitrosative/oxidative stress representing an im-
balance between the production and elimination of RNS and ROS
combined with the reduced production of antioxidants causes oxidative
toxic stress [9].
NO is synthesized by three isoforms of nitric oxide synthases (NOS),
namely endothelial (eNOS), neuronal (nNOS) and inducible (iNOS), all
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of which can be expressed in the heart [10].
Inducing MI in animals using isoproterenol (ISO) is considered a
model established to study the beneﬁcial eﬀects of diﬀerent cardio-
protective agents [11]. ISO, a synthetic β-adrenoceptor agonist, was
found to cause intense oxidative stress in the myocardium and an in-
farcted necrosis of the heart tissue [12]. Besides the positive inotropic
and chronotropic eﬀects of ISO via β adrenergic receptors and the in-
duction of partial ischemia due to myocardial hyperactivity and cor-
onary hypotension, the following mechanisms contribute to ISO-in-
duced MI: increased cyclic adenosine monophosphate, intracellular
Ca2+ overload, diminution of high-energy phosphate supplies, oxida-
tive stress and increased production of cytotoxic free radicals [1,2]. The
heart weight signiﬁcantly increases, and the body weight slightly
changes in ISO-induced MI [13,14].
The disadvantages of other experimental animal models of MI, e.g.
banding, β-adrenergic agonist microinfusion and ligation, include in-
fection, post-injury complications and a higher mortality [2]. On the
other hand, the empirical advantages of ISO-induced MI models include
reproducibility, rapidity, simplicity and non-invasiveness with the po-
tential of mimicking acute clinical MI [2] in the subendocardium of the
left ventricle with acute extensive myoﬁbrillary degeneration [15].
As a mixture of diﬀerent free amino acids and neurotrophic factors,
cerebrolysin (CBL) is widely used for treating stroke given its ameli-
orative eﬀects on the nervous system [16]. By promoting CAT and SOD
scavenging activities, CBL eliminates free radicals and decreases ROS
and free radicals in the mitochondria of nerve cells [16]. The novelties
of the present research include exploring the post-treatment antioxidant
properties of CBL in MI, which is lacking in literature despite addressing
pre-treatments using CBL [17]. The present study was therefore con-
ducted to investigate the ameliorative and antioxidant eﬀects of CBL
against ISO-induced MI in rats.
2. Materials and methods
2.1. Animals
Adult male Wistar rats weighing 150–200 g used in the present
study were collected from the Physiology Research Center in Kashan
University of Medical Sciences, Kashan, Iran. The animals were kept in
standard cages for one week under a 12-hour light–dark cycle at
22–24 °C with 50% humidity before conducting the experiment. The
animals had free access to food and water. All the experimental pro-
cedures were conducted according to the ethical guidelines of Kashan
University of Kashan Medical Sciences, and the study was registered by
the Ethics Committee of the university (code:
IR.KAUMS.MEDNT.REC.1397.013).
2.2. Drugs
ISO was purchased from Merck, Germany, and CBL (vial 5ml) from
EVER Neuro Pharma GmbH, Austria, while every 1ml contained
215.2 mg of CBL.
2.3. MI induction
To empirically induce MI, (100mg/kg/day) of fresh ISO prepared
by being dissolved in physiological saline was subcutaneously injected
in the rats every 24 h for two consecutive days [18].
2.4. Experimental protocols
After the acclimatization, l8 Wistar rats were divided into three
groups of 6. Group 1, i.e. vehicle-treated control rats, were sub-
cutaneously injected with saline for 2 days and intraperitoneally in-
jected with saline for 7 days. Group 2, i.e. ISO-treated (vehicle+ ISO)
rats were subcutaneously given 100mg/kg/day of ISO for 2 consecutive
days and intraperitoneally injected with saline for 7 days. Group 3, i.e.
CBL-treated (CBL+ ISO) rats, were subcutaneously given 100mg/kg/
day of ISO for 2 consecutive days and then intraperitoneally injected
with 5ml/kg of CBL for 7 days [17,18]. The drug doses were selected
based on previously-conducted studies [18].
2.5. Serum biochemical assays
The blood samples were collected from the tail vein on the 3rd day
24 h after the second injection of ISO for the measurement of CK-MB
and cTnI markers. Before sacriﬁcing the rats, blood samples were col-
lected via the cardiac puncture on the 10th day 24 h after the ﬁnal
injection of CBL for the measurement of antioxidants and lipid proﬁles.
2.6. Biochemical analysis
2.6.1. Cardiac biomarkers
Commercially available kits (Zellbio, Germany) were used in spec-
trophotometry to measure the serum levels of CK-MB isoenzyme at
450 nm, and ELISA (Mybiosourc, the US) to measure cTnI as markers
for cardiac damage [17].
2.6.2. LPO
MDA levels were measured as per the method proposed by Ohkawa
et al. [19] to determine LPO in the heart tissue in terms of nmol/mg
protein [17].
2.6.3. Lipid proﬁles
Serum levels of total cholesterol (TC), triglycerides (TG) and HDL
were measured according to routine procedures using commercially
available kits (Pars Azmoon, Iran). Serum levels of LDL were measured
using the Friedewald formula, i.e. LDL=TC− [HDL+TG / 5], and
serum levels of VLDL using the Nobert formula, i.e. VLDL=TG / 5
[20].
2.6.4. Antioxidant markers
The activities of CAT, SOD and GPX were measured using ELISA
according to the instructions of the manufacturer (Zellbio, Germany).
2.6.5. NO
NO levels were determined in the heart tissue in terms of nmol/mg
protein by measuring its supernatant metabolites using the Griess re-
agent and according to the method proposed by Moshage et al. [21].
2.6.6. Total protein
Total protein levels were measured in the heart tissue using the
Bradford method and the concentrated Coomassie blue reagent and
bovine serum albumin as the standard [22].
2.7. Histopathological examinations
After terminating the experiments and sacriﬁcing the animals, the
heart of each rat was immediately excised and washed with phosphate
buﬀer saline. The cardiac apex of the samples was then excised and
ﬁxed in a 10% formaldehyde buﬀer solution. The apex tissues were
embedded in paraﬃn. The sectioned tissues were then stained with
hematoxylin and eosin to evaluate the histological necrosis. The pre-
pared 4-μm thick slides were separately examined by two blinded pa-
thologists under the light microscopy on the histopathological photo-
micrographs. The histological ﬁndings were reported for each specimen
in order of the severity of myocardial necrosis. Based on a minimum 10
ﬁelds for each specimen, the slides were evaluated for myocardial ne-
crosis, inﬂammatory cell inﬁltration and edema and accordingly scored
on a scale of severe (+++), moderate (++), mild (+) and nothing
(O) [23].
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2.8. Statistical analysis
The Kolmogorov-Smirnov test was used to investigate the distribu-
tion normality of all the data. The data were presented as
mean ± SEM, and analyzed using one-way ANOVA followed by the
Tukey's post-hoc test. P < 0.05 was set as the level of statistical sig-
niﬁcance.
3. Results
3.1. Cardiac biomarkers
Twenty four hours after the second injection of ISO on the third day,
the serum levels of cardiac markers (CK-MB and cTnI) signiﬁcantly
increased in the ISO-treated and CBL-treated groups compared to in the
controls (P < 0.05) (Fig. 1A and B).
3.2. Serum antioxidant markers
Fig. 2A–C show the eﬀect of CBL on the activities of serum levels of
CAT, GPX and SOD in all the groups. A signiﬁcant decrease was ob-
served in the antioxidant activities of CAT (P < 0.05) and GPX
(P < 0.05) in the ISO-treated rats compared to in the controls, al-
though the change in SOD was insigniﬁcant (P > 0.05). A signiﬁcant
increase was also observed in the antioxidant activity of CAT
(P < 0.01) and GPX (P < 0.05) in the CBL-treated group (5ml/kg/
i.p.) compared to in the ISO-treated group, although the change in SOD
was insigniﬁcant (P > 0.05).
3.3. LPO
Fig. 3A shows the eﬀect of CBL post-treatment on LPO in all the
experimental groups. A signiﬁcant increase in MDA levels was observed
in the heart tissue in the ISO-treated group compared to in the controls
(P < 0.05). The post-treatment with CBL (5ml/kg/i.p.) signiﬁcantly
decreased MDA levels in the heart tissue compared to the ISO-treated
group (P < 0.001).
3.4. NO
A signiﬁcant increase in NO metabolites measured as nitrite was
Fig. 1. The CK-MB (ng/ml) (A) and the cTnI (pg/ml) (B) levels in serum on the
3rd day, 24 h after the second injection of ISO in three groups (n=6). CON,
control; ISO, isoproterenol; CBL, cerebrolysin; CK-MB, creatine phosphokinase.
Data are expressed as mean ± SEM. * indicates signiﬁcant diﬀerence com-
pared to control group (P < 0.05).
Fig. 2. The activity of CAT (U/mL) (A), the activity of GPX (U/mL) (B) and the
activity of SOD (U/mL) (C) in serum, one week after ISO treatment in three
groups (n=6). CON, control; ISO, isoproterenol; CAT, catalase; GPX, glu-
tathione peroxidase; SOD, superoxide dismutase; CBL, cerebrolysin. Data are
expressed as mean ± SEM. * indicates signiﬁcant diﬀerence compared to
control group (P < 0.05). + indicates signiﬁcant diﬀerence compared to ISO
group (P < 0.05).
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observed in the heart tissue in the ISO-treated group (P < 0.001)
compared to the controls. A signiﬁcant reduction in NO metabolite le-
vels was also observed in the heart tissue in the CBL-treated group
compared to in the ISO-treated group (P < 0.001) (Fig. 3B).
3.5. Lipid proﬁles
Table 1 shows the eﬀect of post-treatment with CBL on lipid proﬁles
in all the groups. No signiﬁcant diﬀerences were observed among the
groups in term of lipid proﬁles (P > 0.05).
3.6. Histopathological examinations
Table 2 and Fig. 4 show the histological changes in myocardial
tissues in all the groups. The light microscopy of the myocardium tissue
sections showed a normal cell without any myocyte necrosis, edema
and inﬂammatory cells in the control group. The histopathological
ﬁndings showed an infarcted zone with massive necrosis of myocyte,
edema and inﬂammatory cells in the ISO-treated myocardium. A focal
area of infarction with coagulative necrosis and vascular proliferation
with mild inﬂammatory cells and edema were observed in the CBL-
treated group.
4. Discussion
The present results found CBL administration to cause signiﬁcant
ameliorative eﬀects on the experimental ISO-induced MI in the rats. In
addition, a signiﬁcant increase in serum cTnI and CK-MB in the samples
conﬁrmed the development of MI in the rats. These ﬁndings are con-
sistent with studies performed on ISO-treated rats [12,24] to conﬁrm
MI models. ISO is a synthetic catecholamine that induces MI based on
an imbalance between oxidants and antioxidants in the heart [12,25].
Administering ISO causes cardiac hyperactivity and therefore increases
the heart demand for oxygen, resulting in a prolonged ischemia and
depletion of ATP [26,27]. The damaged cardiac cells with increased
muscle contractility increase the cell membrane permeability and allow
cardiac enzymes to leak out into the bloodstream [26,27]. cTnI and CK-
MB predominantly localized in the heart are considered valuable di-
agnostic markers for MI given that both are elevated by myocardium-
speciﬁc damage [25,28]. In line with literature [12,24,27], the present
histopathological ﬁndings conﬁrmed the ISO-induced myocardial da-
mage.
An increase in oxidative stress during and following MI has been
widely reported in literature [2,29]. In this process, the stimulation of β
adrenergic receptors by ISO causes the oxidation of lipids and genera-
tion of enormous amounts of ROS in the myocardium [7]. Intense LPO
caused by ISO can aﬀect the mitochondria and cell membranes, and
result in more severe oxidative damage in the heart, and release MDA
into the blood circulation [30]. Increased MDA levels contribute to an
increased generation of free radicals and decreased activities of the
antioxidant defense system [8].
The levels of free radicals in oxidative injuries are controlled by
diﬀerent cellular defense mechanisms, including CAT, GPX and SOD
[31]. Administering ISO in the present study caused a signiﬁcant de-
crease in endogenous antioxidants, including CAT and GPX and ex-
cluding SOD. Administering ISO also markedly increased MDA levels,
suggesting the induction of oxidative stress. Furthermore, post-treat-
ment with CBL decreased MDA levels in the heart tissue and increased
the activity of serum CAT and GPX. The present ﬁndings support the
scavenging activity of CBL caused by these antioxidants. CBL was re-
cently shown to reduce oxidative stress and LPO in rats as a result of
ISO-induced MI [17]. The antioxidant properties of CBL were reported
Fig. 3. The level of MDA (nmol/mg protein) (A) and the level of NO (nmol/mg
protein) (B) in heart tissue one week after ISO treatment in three groups
(n=6). CON, control; ISO, isoproterenol; MDA, malondialdehyde; NO, nitric
oxide; CBL, cerebrolysin. Data are expressed as mean ± SEM. * indicates sig-
niﬁcant diﬀerence compared to control group (P < 0.05). + indicates sig-
niﬁcant diﬀerence compared to ISO group (P < 0.05).
Table 1
Eﬀect of post-treatment with CBL on lipid proﬁle in serum, one week after
induction of MI with ISO in three groups (n= 6). CON, control; ISO, iso-
proterenol; Chol, cholesterol; TG, triglycerides; HDL, high density lipoprotein;
LDL, low density lipoprotein; VLDL, very low density lipoprotein; CBL, cere-
brolysin. Data are expressed as mean ± SEM.
Group CON ISO CBL+ ISO
Chol 68.8 ± 5.4 60.5 ± 3.7 76 ± 2.1+
TG 100.2 ± 8.4 71.5 ± 5.1⁎ 106.5 ± 7.8++
HDL 31.4 ± 2.2 36.7 ± 1.9 30.1 ± 1.6
LDL 11.3 ± 1.06 12.3 ± 1.4 11.9 ± 2.04
VLDL 20.04 ± 1.6 14.31 ± 1⁎ 21.3 ± 1.5++
⁎ Indicates signiﬁcant diﬀerence compared to control group (P < 0.05).
+ Indicates signiﬁcant diﬀerence compared to ISO group (P < 0.05).
Table 2
Eﬀect of CBL on histopathological changes in the ISO-induced MI in rats. ISO,
isoproterenol: CON, control; CBL, cerebrolysin. CON: received 2 days injections
of saline (sc) and 7 days injections of saline (ip); ISO: received 2 days injections
of isoproterenol (100mg/kg/sc) and 7 days injections of saline (ip); CBL+ ISO:
received 2 days injections of isoproterenol (100mg/kg/sc) and 7 days injections
of CBL (5ml/kg/ip).
Group Myonecrosis Angiogenesis Inﬂammation Edema
CON O O O O
ISO +++ O +++ +++
CBL+ ISO +++ ++ ++ ++
Histopathological changes; (O) no change, (+) mild, (++) moderate, (+++)
severe.
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to be associated with its ability to promote certain activities of anti-
oxidant enzymes and enhance the ROS scavenger system and reduce
free radical reactions to protect the mitochondrial of nerve cells against
damage by toxicants [16].
CBL was also found to decrease the serum levels of SOD in rats with
brain injuries [32]. In contrast to the present study that did not suggest
an increase in SOD activities in post-treatment CBL, pre-treatment CBL
has been shown to increase SOD activities in the heart of ISO-induced
cardiotoxic rats [17]. Loeper et al. reported that free radicals can inhibit
SOD activities [33]. The presence of free radicals by ISO can therefore
be assumed to inhibit SOD activities in both ISO and CBL+ ISO groups.
Lipids play a key role in CVD by modifying the composition,
structure and stability of cell membranes [29]. Cholesterol is also a
major component of atherosclerotic plaques associated with MI. In
contrast to the ﬁnding suggesting that ISO-treated rats develop an
elevated TG, LDL and low HDL levels immediately in the ﬁrst days after
the treatment, which causes myocyte membrane damage [29], the
present results indicated no signiﬁcant diﬀerences in lipid proﬁles one
week after MI induction. This discrepancy of results can be explained by
the fact that the present study evaluated lipid proﬁles one week after
the treatment, which inhibited the detection of changes in lipid proﬁle
levels.
The present study showed a signiﬁcant elevation in the heart tissue
levels of NO in the ISO group, whereas post-treatment with CBL sig-
niﬁcantly attenuated them, which is consistent with previous studies;
for instance, Kralova et al. reported that increased NO production in
oxidative stress can cause cellular injuries through toxic peroxynitrite
formation [10]. Moreover, Dong et al. found CBL to inhibit the ab-
normal metabolism of NO and reduce apoptosis [16]. Moreover, Zurita
et al. found an increase in left ventricular nitrite levels to homogenate
in CBL-treated diabetic rats [34]. The mechanisms contributing to the
decrease in NO levels with CBL administration could be best explained
by the direct inhibitory eﬀects of iNOS by CBL, as CBL inhibits LPO
through NO pathways; nevertheless, further studies are recommended
to be performed to conﬁrm the present results.
The histopathological ﬁndings showed an infarcted zone with
myocardial necrosis, interstitial edema, increased macrophage activity
and scar formation in the ISO-treated rats. A moderate ameliorative
eﬀect on MI was also observed in the CBL-treated group. Administering
CBL after inducing an experimental heart injury in the animal models
merely showed a moderate reduction in tissue inﬂammation and edema
potentially due to inducing vascular proliferation in the heart tissue
[18]. The present results, however, showed that the antioxidant activ-
ities of CBL are more potent than its anti-inﬂammatory eﬀects.
To the best of the authors' knowledge, the antioxidant properties of
post-treatment CBL in MI have rarely been reported in literature. The
present study was therefore a pioneer of reporting the antioxidant and
ameliorative eﬀects of post-treatment CBL in rats with isoproterenol-
induced MI.
In a nutshell, the present histopathological and biochemical ﬁndings
suggest that CBL has antioxidant properties in the myocardium and
exerts beneﬁcial eﬀects on ISO-induced MI. The abilities to decrease
LPO and NO production and increase the CAT and GPX activity con-
stitute the major ameliorative mechanisms of CBL. The ameliorative
and antioxidant eﬀects of CBL on ISO-induced MI are therefore con-
ﬁrmed in rats.
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